Raheleh Farahzadi
Overview
Explore the profile of Raheleh Farahzadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farahzadi R, Fathi E, Vandghanooni S, Valipour B
Regen Ther
. 2024 Sep;
26:646-653.
PMID: 39281104
Objective: The effect of mesenchymal stem cells (MSCs) on the immortal characteristics of malignant cells, particularly hematologic cancer cells, remains a topic of debate, with the underlying mechanisms still requiring...
2.
Valipour B, Fathi E, Farahzadi R, Naderali E, Behniafar H
Tissue Cell
. 2024 Sep;
91:102558.
PMID: 39260072
Background: Stem cell-based therapy has emerged as an attractive approach for regenerative medicine. Poor survival and maintenance of the cells used in regenerative medicine are considered as serious barriers to...
3.
Farahzadi R, Fathi E, Vandghanooni S, Valipour B
Biochim Biophys Acta Rev Cancer
. 2024 Sep;
1879(5):189177.
PMID: 39218403
Cell therapy has emerged as one of the most promising approaches to treating disease in recent decades. The application of stem cells in anti-tumor therapy is determined by their varying...
4.
Farboud S, Fathi E, Valipour B, Farahzadi R
J Transl Med
. 2024 Aug;
22(1):783.
PMID: 39175068
A novel approach to treating heart failures was developed with the introduction of iPSC technology. Knowledge in regenerative medicine, developmental biology, and the identification of illnesses at the cellular level...
5.
Fathi E, Valipour B, Jafari S, Kazemi A, Montazersaheb S, Farahzadi R
Heliyon
. 2024 Aug;
10(15):e35051.
PMID: 39157371
Hematopoietic stem cells (HSCs) are tightly regulated by specific microenvironments called niches to produce an appropriate number of mature blood cell types. Self-renewal and differentiation are two hallmarks of hematopoietic...
6.
Mazloumi Z, Rafat A, Dizaji Asl K, Karimipour M, Shanehbandi D, Talebi M, et al.
Bioimpacts
. 2024 Aug;
14(4):27640.
PMID: 39104619
Introduction: High metastasis, resistance to common treatments, and high mortality rate, has made triple-negative breast cancer (TNBC) to be the most invasive type of breast cancer. High telomerase activity and...
7.
Farahzadi R, Fathi E, Valipour B, Ghaffary S
Int J Cardiol Heart Vasc
. 2024 Apr;
52:101399.
PMID: 38584674
Heart failure is a root cause of morbidity and mortality worldwide. Due to the limited regenerative capacity of the heart following myocardial injury, stem cell-based therapies have been considered a...
8.
Montazersaheb S, Farahzadi R, Fathi E, Alizadeh M, Abdolalizadeh Amir S, Ardakan A, et al.
Heliyon
. 2024 Mar;
10(5):e26959.
PMID: 38455550
Background: The discovery of novel cancer therapeutic strategies leads to the development of nanotechnology-based methods for cancer treatment. Silver nanoparticles (Ag-NPs) have garnered considerable interest owing to their size, shape,...
9.
Farahzadi R, Valipour B, Fathi E, Pirmoradi S, Molavi O, Montazersaheb S, et al.
Stem Cell Res Ther
. 2023 Nov;
14(1):342.
PMID: 38017510
Epithelial-mesenchymal transition (EMT) is a cell remodeling process in which epithelial cells undergo a reversible phenotype switch via the loss of adhesion capacity and acquisition of mesenchymal characteristics. In other...
10.
Valipour B, Davari S, Farahzadi R, Pourrasol S, Mehran N, Dizaji Asl K, et al.
Cell Biochem Funct
. 2023 Nov;
41(8):1477-1487.
PMID: 38014526
Acute myeloid leukemia (AML) is a highly lethal hematological malignancy in adults and children. Abnormal proliferation of leukemia stem cells (LSC) with CD34 and CD38 phenotypes are the main clinical...